Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study
- PMID: 34003765
- PMCID: PMC8163493
- DOI: 10.2196/29583
Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study
Erratum in
-
Correction: Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study.J Med Internet Res. 2021 Jul 16;23(7):e32120. doi: 10.2196/32120. J Med Internet Res. 2021. PMID: 34270442 Free PMC article.
Abstract
Background: Persistent olfactory dysfunction is a significant complication of SARS-CoV-2 infection. Olfactory training involving aromatic oils has been recommended to improve olfactory recovery, but quantitative data are missing.
Objective: We aimed to quantify the benefit of olfactory training and visual stimulation assisted by a dedicated web application for patients who experienced olfactory dysfunction for ≥1 month.
Methods: We performed an observational, real-life, data-based study on a cohort of patients who experienced at least 1 month of persistent olfactory dysfunction between January 30 and March 26, 2021. An analysis was performed after a mean olfactory training time of 4 weeks, and at least 500 patients were assessable for primary outcome assessment. Participants exposed themselves twice daily to odors from 4 high-concentration oils and visual stimulation assisted by a dedicated web application. Improvement was defined as a 2-point increase on a 10-point, self-assessed olfactory visual analogue scale.
Results: In total, 548 patients were assessable for primary outcome assessment. The mean baseline, self-assessed olfactory score was 1.9 (SD 1.7), and this increased to 4.6 (SD 2.8) after a mean olfactory training time of 27.7 days (SD 17.2). Olfactory training was associated with at least a 2-point increase in 64.2% (352/548) of patients. The rate of patients' olfactory improvement was higher for patients who trained for more than 28 days than that rate for patients who trained for less than 28 days (73.3% vs 59%; P=.002). The time to olfactory improvement was 8 days faster for patients with hyposmia compared to the time to improvement for patients with anosmia (P<.001). This benefit was observed regardless of the duration of the olfactory dysfunction.
Conclusions: Olfactory training and visual stimulation assisted by a dedicated web application was associated with significant improvement in olfaction, especially after 28 days of olfactory training.
Keywords: COVID-19; SARS-CoV-2; app; dysfunction; nose; observational; olfactory; olfactory dysfunction; olfactory training; real-life study; senses; smell; stimulation; training; web application, eHealth.
©Fabrice Denis, Anne-Lise Septans, Lea Periers, Jean-Michel Maillard, Florian Legoff, Hirac Gurden, Sylvain Moriniere. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.05.2021.
Conflict of interest statement
Conflicts of Interest: FD and FL are founders of Kelindi. The other authors have no conflicts of interest.
Figures
Similar articles
-
Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.JAMA Otolaryngol Head Neck Surg. 2023 Feb 1;149(2):141-149. doi: 10.1001/jamaoto.2022.4112. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36580304 Free PMC article.
-
Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.Eur Arch Otorhinolaryngol. 2023 May;280(5):2351-2358. doi: 10.1007/s00405-022-07788-8. Epub 2022 Dec 15. Eur Arch Otorhinolaryngol. 2023. PMID: 36520209 Free PMC article.
-
Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial.Am J Rhinol Allergy. 2022 Nov;36(6):780-787. doi: 10.1177/19458924221113124. Epub 2022 Jul 21. Am J Rhinol Allergy. 2022. PMID: 35866202 Free PMC article. Clinical Trial.
-
Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.Am J Rhinol Allergy. 2023 Jan;37(1):95-101. doi: 10.1177/19458924221120117. Epub 2022 Aug 11. Am J Rhinol Allergy. 2023. PMID: 35957578 Free PMC article. Review.
-
Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.Ann Otol Rhinol Laryngol. 2023 Jul;132(7):806-817. doi: 10.1177/00034894221118186. Epub 2022 Aug 12. Ann Otol Rhinol Laryngol. 2023. PMID: 35959948 Review.
Cited by
-
Comparative Analysis of Olfactory and Gustatory Function of Patients With COVID-19 Olfactory Dysfunction and Non-COVID-19 Postinfectious Olfactory Dysfunction.J Korean Med Sci. 2023 Nov 6;38(43):e352. doi: 10.3346/jkms.2023.38.e352. J Korean Med Sci. 2023. PMID: 37935167 Free PMC article.
-
Odor familiarity and improvement of olfactory identification test in Chinese population.Front Psychol. 2023 Oct 16;14:1278668. doi: 10.3389/fpsyg.2023.1278668. eCollection 2023. Front Psychol. 2023. PMID: 37908819 Free PMC article.
-
[Persistent olfactory impairment after COVID-19-recommendations of the Working Group on Olfactology and Gustology of the German Society of Oto-rhino-laryngology, Head and Neck Surgery].HNO. 2023 Nov;71(11):739-743. doi: 10.1007/s00106-023-01368-w. Epub 2023 Oct 6. HNO. 2023. PMID: 37801102 Free PMC article. Review. German.
-
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies.Biomedicines. 2023 Aug 3;11(8):2189. doi: 10.3390/biomedicines11082189. Biomedicines. 2023. PMID: 37626685 Free PMC article. Review.
-
Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.PLoS One. 2023 Aug 2;18(8):e0288285. doi: 10.1371/journal.pone.0288285. eCollection 2023. PLoS One. 2023. PMID: 37531338 Free PMC article.
References
-
- Barón-Sánchez J, Santiago C, Martín GGS, Arca R, Fernández R. Smell and taste disorders in Spanish patients with mild COVID-19. Neurologia. 2020;35(9):633–638. doi: 10.1016/j.nrl.2020.07.006. http://www.elsevier.es/en/linksolver/ft/pii/S0213-4853(20)30233-4 - DOI - PMC - PubMed
-
- Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020 May 11;35(18):e174. doi: 10.3346/jkms.2020.35.e174. https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e174 - DOI - PMC - PubMed
-
- Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, Boscolo-Rizzo P. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020 May 26;323(20):2089–2090. doi: 10.1001/jama.2020.6771. http://europepmc.org/abstract/MED/32320008 - DOI - PMC - PubMed
-
- Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Chiesa-Estomba CM, Salzano G, Cucurullo M, Salzano FA, Saussez S, Boscolo-Rizzo P, Biglioli F, De Riu G. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug;134(8):703–709. doi: 10.1017/S0022215120001826. http://europepmc.org/abstract/MED/32782030 - DOI - PMC - PubMed
-
- Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S, Barillari MR, Cammaroto G, Fakhry N, Martiny D, Ayad T, Jouffe L, Hopkins C, Saussez S, COVID-19 Task Force of YO-IFOS Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020 Sep;288(3):335–344. doi: 10.1111/joim.13089. http://europepmc.org/abstract/MED/32352202 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
